(Q51989995)

19 April 2018

title

Therapeutic effects of Ag85B and MPT64 DNA vaccines in a murine model of Mycobacterium tuberculosis infection. (English)

1 reference

19 April 2018

Mycobacterium tuberculosis

main subject

0 references

1 reference

Daoyin Zhu

1

1 reference

19 April 2018

Shan Jiang

series ordinal

2

1 reference

19 April 2018

Xudong Luo

series ordinal

3

1 reference

19 April 2018

language of work or name

English

0 references

publication date

1 August 2005

1 reference

19 April 2018

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

19 April 2018

volume

23

1 reference

19 April 2018

issue

37

1 reference

19 April 2018

page(s)

4619-4624

1 reference

19 April 2018

Immunology of tuberculosis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.035

Prospects for new interventions in the treatment and prevention of mycobacterial disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.035

M. tuberculosis: immunology and vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.035

The pathogenesis of tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.035

The many faces of host responses to tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.035

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.035

Therapy of tuberculosis in mice by DNA vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.035

Interleukin-7 or interleukin-15 enhances survival of Mycobacterium tuberculosis-infected mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.035

An antimicrobial activity of cytolytic T cells mediated by granulysin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.035

Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.035

Therapeutic effect of DNA vaccines combined with chemotherapy in a latent infection model after aerosol infection of mice with Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.035

Tuberculosis vaccine development: recent progress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.035

High sensitivity of transgenic mice expressing soluble TNFR1 fusion protein to mycobacterial infections: synergistic action of TNF and IFN-gamma in the differentiation of protective granulomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.035

Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.035

Pulmonary necrosis resulting from DNA vaccination against tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.035

DNA immunization in a mouse model of latent tuberculosis: effect of DNA vaccination on reactivation of disease and on reinfection with a secondary challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.035

Reactivation of latent tuberculosis: variations on the Cornell murine model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.035

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2005.05.035

1 reference

19 April 2018

1 reference

19 April 2018